About Biolinq
Biolinq Incorporated is a medical device company that has developed a revolutionary needle-free continuous glucose monitoring platform. The company's flagship product, Biolinq Shine, is an FDA-cleared autonomous intradermal glucose sensor that uses an array of ultra-small electrochemical microsensors combined with an accelerometer and ambient light sensor. Unlike traditional CGM devices, Biolinq Shine requires no hypodermic needle for insertion and features a unique LED light system that provides real-time visual feedback on glucose levels—blue indicates target range, yellow signals high glucose. The device automatically tracks physical activity and sleep patterns to provide contextual insights into how lifestyle factors impact glucose levels. The system is designed for persons 22 years or older not on insulin to aid in the management of conditions related to glycemic control. Biolinq's proprietary microarray platform technology has been developed over 10 years with $120 million in investment and over 500,000 hours of clinical data. The company's multi-sensor platform has potential applications beyond glucose monitoring, with partnerships with leading universities and bioengineering institutions exploring additional biomarker sensing capabilities. The company brings together expertise in biosensor design, consumer electronics, software-derived insights, microarray platform architecture, and proprietary materials science, with a leadership team drawing from extensive experience at companies like Dexcom, Medtronic, and other major medical device manufacturers.
Mission & Story
Mission
Sensing your path to better health
Founding Story
Co-founded by Jared Tangney, PhD, who spent a decade in micro-array sensor research and development. The company was founded to reimagine biosensing from just below the surface of the skin and engineer a new category of sensors that opens possibilities to deliver new insights about health.
Clinical Focus
Medical conditions and clinical areas addressed by Biolinq.
Who It Serves
Milestones & Awards
Recent Milestones
FDA clearance for Biolinq Shine Autonomous Time-in-Range Microsensor. $120 million invested in platform development.
Awards & Recognition
Established new category of wearable glucose sensors for metabolic health with FDA De Novo Classification
Key Partnerships
Company Details
- Headquarters
- San Diego, CA, USA
- Employees
- 51-200
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 63 →
Acurable
Acurable creates accurate and user-friendly wearable medical devices for at-home monitoring of sleep apnea, epilepsy, COPD, and asthma.
Aktiia
Aktiia develops optical blood pressure monitoring technology integrated into wearable devices for continuous, cuffless blood pressure tracking. The company focuses on enabling remote patient monitoring and hypertension management through clinically validated wearable solutions.
August Health
August Health provides an AI-enabled EHR platform designed specifically for senior living communities. The platform includes integrated modules for electronic health records, medication management (eMAR), move-ins, billing, care tracking, and predictive analytics to help operators shift from reactive to proactive care strategies.
Babyscripts
Babyscripts is a market-leading digital maternity care platform that combines remote patient monitoring, care management, and patient engagement tools to improve maternal health outcomes across prenatal and postpartum care for health systems, payers, and private practices.
Belun Technology Company
11-50 employees
Belun Technology develops FDA-cleared AI-powered wearable ring technology for sleep apnea diagnosis and continuous health monitoring. The company provides medical-grade sleep diagnostics that bridge the gap between home and hospital care.
Binah.ai
Binah.ai provides an AI-powered, video-based, 100% software solution that enables measurement of vital signs and health indicators using smartphone or tablet cameras. In 35 seconds, users can measure vital signs, chronic disease risks, stress levels, and bloodless blood tests without wearables or equipment.
Biobeat
Biobeat develops FDA-cleared cuffless ambulatory blood pressure monitoring (ABPM) solutions using a wireless, non-invasive chest patch. The company enables 24-hour hypertension monitoring for cardiologists, nephrologists, and hypertension centers to improve diagnosis accuracy and treatment management.
Biofourmis
growth · 350 employees
Biofourmis provides a connected technology platform that partners with health systems, hospitals, and payers to revolutionize care delivery across the continuum.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.